About Fate
Why Fate? Why Now?
Founded in 2007 on the leading stem cell and developmental biology research, Fate Therapeutics is using the fundamental biological mechanisms that guide cell fate to develop stem cell therapeutics. The company has brought together the foremost scientists from the nation’s research hotbeds (Boston, San Francisco, San Diego and Seattle) who have demonstrated the potential to create and modulate stem cells to restore health.
While embryonic stem cells opened the possibility for regenerative medicine, Fate Therapeutics is focusing on adult stem cells and induced pluripotent stem (iPS) cells.
- Adult stem cells naturally exist in tissues or organs and are responsible for maintaining and repairing the tissue in which they are found.
- iPS cells are stem cells created from fully mature differentiated cells, like a skin cell, and promise to be of great use for drug discovery and development and personalized cell replacement therapies.
Fate is using conventional drug discovery and iPS cell technology to identify small molecules and biologics to develop therapeutics for diseases and conditions that currently have limited to no treatment options.
Fate Therapeutics was named by Technology Review one of the 50 most innovative companies in the world. To read more, click here.
Visit our corporate fact sheet.